John C.M. Farquhar Sells 27,230 Shares of Heartflow (NASDAQ:HTFL) Stock

Posted by Mark Dietrich on Aug 27th, 2026

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CEO John C.M. Farquhar sold 27,230 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer directly owned 360,814 shares of the company’s stock, valued at $18,040,700. The trade was a 7.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

On Tuesday, August 18th, John C.M. Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total value of $607,773.60.
On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total value of $626,095.50.
On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00.
On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.50, for a total value of $643,017.00.

Heartflow Stock Performance

Heartflow stock opened at $48.94 on Thursday. The stock has a market cap of $4.26 billion and a PE ratio of -26.74. The stock has a 50-day moving average of $31.68 and a two-hundred day moving average of $28.79. Heartflow, Inc. has a one year low of $20.13 and a one year high of $51.19.

Heartflow (NASDAQ:HTFL – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business’s revenue for the quarter was up 47.7% compared to the same quarter last year. As a group, sell-side analysts predict that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

HTFL has been the topic of several research reports. Wells Fargo & Company upped their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Benchmark restated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Morgan Stanley upped their target price on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. Canaccord Genuity Group raised their price target on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. Finally, Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $43.43.

View Our Latest Stock Analysis on Heartflow

Institutional Investors Weigh In On Heartflow

A number of hedge funds and other institutional investors have recently made changes to their positions in HTFL. XXEC Inc. acquired a new position in shares of Heartflow in the 2nd quarter valued at $2,524,764,000. BlackRock Inc. acquired a new position in shares of Heartflow in the second quarter worth about $152,502,000. Wellington Management Group LLP purchased a new stake in shares of Heartflow during the 3rd quarter worth about $164,263,000. Bamco Inc. NY purchased a new position in shares of Heartflow in the 2nd quarter valued at about $94,625,000. Finally, Jupiter Topco LLC acquired a new position in Heartflow in the 2nd quarter worth about $70,983,000.

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.